Mobile Thinking Intervention: A Inital Test
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT06909422
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Clinical High Risk for Psychosis (CHR)
- Schizophrenia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mobile Intervention for Biased Thinking — BEHAVIORALThis intervention will be delivered via a mobile application.
Study Details
This study will test the inital efficacy of a brief mobile intervention targeting biased thinking.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Dec 2025
- Primary completion
- Aug 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Mobile Intervention to Target Biased Thinking
Primary Outcome Measure
Defeatist Beliefs Scale - 15 [ Time Frame: Measured at Baseline and post intervention (6 weeks) ]
Central Contacts
- Lauren Luther205-530-1117
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35223-1517 |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Related Studies
- Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsPHASE3 · Enrolling By Invitation · Alkermes, Inc. · Dothan, Alabama
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderPHASE3 · Recruiting · Alkermes, Inc. · Dothan, Alabama
- Zyprexa® Relprevv™ Patient Care ProgramEnrolling By Invitation · Eli Lilly and Company · Blue Bell, Pennsylvania
- Database Registry for Neural Network Biomarkers in PsychosisRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas